10 results
To determine the performance (safety and effectiveness) of miniaturo*-I for the treatment of urinary urge incontinence.
Primary objective• To validate the potential of Vasovist®-enhanced MRI for accurate prediction of nodal status in patients with primary rectal cancer using histopathological examination after surgery as the SOR.Secondary objectives• To compare the…
The primary research question is:-What is the influence of cognitive functioning on on the quality of life after SAH on the long term?Two secundary research questions are:-Is there a specific neuropsychological profile after SAH on the long term?-…
In an effort to collect safety and effectiveness information on the stent, Medlogics is conducting the Cobra II study.
Safety and electrical performance evaluation of Invicta leads moodels equipped with DF-4-connector.Clinical study to support the submission for acquiring the CE-mark.
The effect of body composition on the farmacokinetiek IFX in patients with inflammtoy bowel disease;
The aim of the studie is to determine the correlation between fat mass end the IFX concentration. Primary research question:What is the effect of fat mass percentage, measured by a validated scale, and secundaire skinfold measurement, waist…
Our main objective is to evaluate the effect of RAS inhibition on ascending aortic dilatation rate by cardiac magnetic resonance (CMR) imaging in CoA patients, and compare this to CoA patients without RAS inhibition. As secondary objectives, we aim…
The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presentingwith Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation utilizing the…
This study has multiple purposes:Primary objective:1: to investigate whether it is possible to identify the small mimic muscles independently of each other and to determine the exact position of the mimic muscles from origin to insertion on MRI…
The primary objective of the study is survival on a Carmat device at 180 days post-implant* or survival to cardiac transplantation if occurring before 180 days post-implant**. * The beginning of the implant procedure is defined as the start of the…